Affiliation
Christie Hospital NHS Trust, Withington, Manchester, UK.Issue Date
1998
Metadata
Show full item recordAbstract
We detail the case history of a patient with Stage I seminoma, who developed an elevated level of human chorionic gonadotrophin (hCG) while on follow-up. It transpired that the patient had injected himself with hCG several days before. This type of abuse has been documented, but this is the first reported case of it interfering with the follow-up of a patient with a germ cell tumour.Citation
Pitfalls of hCG monitoring in stage I seminoma. 1998, 10 (2):131-2 Clin Oncol (R Coll Radiol)Journal
Clinical OncologyDOI
10.1016/S0936-6555(05)80495-9PubMed ID
9610904Type
ArticleLanguage
enISSN
0936-6555ae974a485f413a2113503eed53cd6c53
10.1016/S0936-6555(05)80495-9
Scopus Count
Collections
Related articles
- Elevated human chorionic gonadotropin concentrations in the testicular vein and in peripheral venous blood in seminoma patients. An analysis of various parameters.
- Authors: Hartmann M, Pottek T, Bussar-Maatz R, Weissbach L
- Issue date: 1997
- [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
- Authors: Neumann A, Keller T, Jocham D, Doehn C
- Issue date: 2011 Sep
- Treatment of stage I seminoma: should beta-HCG positive seminoma be treated aggressively?
- Authors: Suzuki K, Nakazato H, Kurokawa K, Suzuki T, Suzuki K, Yamanaka H
- Issue date: 1998
- Monitoring of seminoma patients with serum markers.
- Authors: Hotakainen K, Lempiäinen A, Stenman UH
- Issue date: 2013 Jul 1
- Abnormal hCG levels in a patient with treated stage I seminoma: a diagnostic dilemma.
- Authors: Aherne NJ, Small CA, McVey GP, Fitzpatrick DG, Armstrong JG
- Issue date: 2008 Jun 25